Medical Innovation is ONLY Accessible Through Germline Edits
Sinha 22. (Sinha, [Rohit, Head of Cryptography at Swirlds Labs.] [ARK1] "A CRISPR Framework for Emerging Biotechnology Applications: A Proposal to Separate Science from Politics." J. Health & Biomedical L. 18 (2022): 142. https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/jhbio18§ion=11. shARK)
The democratization of the CRISPR/Cas9 system paired with its fallibility may threaten the safety of society. Researchers Doudna and Charpentier recognize that there are errors associated with CRISPR/Cas9, although many other research scientists have declared that it is the quickest and most efficient of common genome-editing tools such as zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) (1081). The maximum efficiency for genetic engineering in humans, depending on target genes, is approximately 80%, which is higher than observed with other genome editing tools. However, the efficiency is still not high enough. Dr. Emily Leproust, an expert in synthetic biology and CEO of Twist Bioscience, states, “Critical to genome editing are precision and 100% guide representation. Precision (brought about by sequence accuracy of the guides) and effective guide representation are possible only through highly uniform synthesis” (34). CRISPR is also cheaper and easier to assemble than other gene editing tools; and its mechanisms are universal to organisms within all three domains of life (Doudna and Charpentier 1078). Some laboratory procedures using CRISPR/Cas9 techniques are reported to cost as little as $30 (Ledford 21). Its unprecedented affordability and ease of use incited what seemed instant discoveries in the field of genetic engineering. Alternatively, the fact that CRISPR/Cas9 is quick, easy, and affordable may also be the reason for serious mistakes because the system 20 Royal Road lacks the precision necessary for any real-world applications.